Related by context. All words. (Click for frequent words.) 73 duration 62 #:# mediaQueryString http:/static.washingtonposFilmworkers 58 shorter durations 58 Duration 57 intervals 54 rates EURIBORSWD = 54 #:# mediaQueryString http:/static.washingtonpostZanatta 53 #:# mediaQueryString 53 periods 52 QT intervals 52 shorter 51 brightness backlight 50 VO2 peak 50 timepoints 49 Durations 49 QRS duration 49 interquartile range 48 androgen suppression 48 msec 48 acting insulins 48 Tasigna prolongs 47 decrements 47 progression TTP 47 cycles 47 IELT 47 postintervention 47 nonoverlapping 47 telomere lengths 47 predetermined intervals 47 maturities 47 QRS width 46 Intervals 46 Maturities 46 varying lengths 46 frequency 46 #μs [001] 46 crossclamp 46 acting bronchodilators 46 distances 46 non progressors 46 cyclicity 46 convexity 45 WEGENER focuses 45 hypofractionated 45 posttreatment 45 timespan 45 periodicity 45 QTc intervals 45 dose titration 45 dated JGBs 45 dosing interval 45 #μs [002] 45 Soyuz undocking 45 apnea hypopnea 45 oscillation frequency 45 gestation periods 45 follicular phase 45 refuel Lochbaum 45 μsec 45 pulse widths 44 PLMS 44 expiratory flow 44 QTcF 44 bursty traffic 44 dose regimens 44 benign gastric ulcers 44 Kaplan Meier estimate 44 varying durations 44 shortening 44 picoseconds 44 ultrashort 44 severities 44 hypopnea 44 gestations 44 PLMs 44 lifespans 44 submaximal 44 wrist actigraphy 44 Conde Agudelo 44 nonpeak 44 intensities 44 preintervention 44 1ms 43 Hybrid ARMs 43 cardiac morbidity 43 photoperiod 43 Hb levels 43 shiftwork 43 intermittent dosing 43 μs 43 Score DAS# 43 genotypic resistance 43 timescales 43 Apgar scores 43 spirometric 43 gamma ray bursts GRBs 43 Shutter speeds 43 nsec 43 premenopause 43 dosage regimens 42 esophageal acid 42 Kaplan Meier estimates 42 Elidio Guillen 42 circadian cycle 42 virologic failure 42 postinjury 42 tumor histology 42 postprandial blood glucose 42 daytime somnolence 42 oxygen desaturation 42 Auditioning actors 42 postoperative chemotherapy 42 CPAP adherence 42 postoperative mortality 42 pulse durations 42 transaminase levels 42 androgen deprivation 42 timeframes 42 oncologic outcomes 42 symptom onset 42 acromegalic patients 42 aplindore 42 PWM frequency 42 mg kg IV 42 endometrial thickness 42 leucopenia 42 arousals 42 cognitive domains 42 timepoint 42 ± SEM 42 Brisk walking 42 dosed intravenously 42 QTc 42 HAQ DI 42 aminotransferase elevations greater 42 variable 42 cycle ergometer 42 #.#-#.# [011] 42 bearspread 42 Length 42 PMVS 42 linewidth 42 intensity aerobic exercise 42 increments 42 linear interpolation 42 leaf wetness 42 oral corticosteroids 42 postprocedure 42 dual antiplatelet therapy 42 nighttime awakenings 42 neurocognitive function 42 urate lowering therapy 42 timebase 41 producing wellbores 41 cecal intubation 41 ULN 41 androgen ablation 41 Visual Analogue Scale VAS 41 intravaginal ejaculatory latency 41 lacosamide 41 Mycophenolate mofetil 41 EEG readings 41 pulse width 41 neurologic complications 41 varying distances 41 femtoseconds 41 #mg/m# [002] 41 anticoagulant medications 41 wavelength infrared 41 potassium supplementation 41 EDSS scores 41 clopidogrel therapy 41 detraining 41 dosing intervals 41 leadtimes 41 photon flux 41 cortical activation 41 lasts 41 brachial artery flow 41 circadian misalignment 41 PASI score 41 oxyhemoglobin 41 UV wavelengths 41 inflammatory biomarkers 41 virological response 41 methotrexate therapy 41 QTc interval 41 tumor progression TTP 41 diurnal cycle 41 impedances 41 symptomatic intracranial hemorrhage 41 Fasting plasma glucose 41 blood glucose concentrations 41 neutrophil counts 41 lifecycles 41 concentration Cmax 41 lengthen 41 cerebrovascular events 41 bursty 41 salivary cortisol 41 daytime alertness 41 renal cysts 41 MMSE score 41 Our PMVS 41 nocturnal hypoglycaemia 41 shorten 41 tolterodine 41 ± SD 41 continuous intravenous infusion 41 attoseconds 41 recurrent VTE 41 Duration Gap 41 curve steepeners 41 monotonically 41 term Shahar unlinked 41 repeat paracentesis 40 kVp 40 Tmax 40 mean ± SEM 40 bipolar mania trials 40 SpO 2 40 anatomic landmarks 40 plantar pressures 40 corrected QT interval 40 periprocedural 40 shortened 40 milliseconds ms 40 Baseline characteristics 40 telomerase activity 40 prolonged QT interval 40 ABC/3TC 40 extubation 40 dated maturities 40 actigraphy 40 levodopa therapy 40 serum concentrations 40 WOMAC pain 40 INVEGA ® 40 severe neutropenia 40 prolongations 40 ropinirole 40 interfering RNAs siRNAs 40 ADLs 40 rhythmicity 40 focal lengths 40 timeframe 40 claudication 40 rapid virological response 40 telephoto focal 40 rFSH 40 plasma concentration Cmax 40 tapentadol ER 40 activated partial thromboplastin 40 locomotor activity 40 shortterm 40 collected saliva samples 40 linear regression models 40 wavelength ultraviolet 40 onsets 40 cyclic 40 telaprevir dosing 40 ventricular repolarization 40 mm ³ 40 dosing regimens 40 CK # plasma concentrations 40 dipyridamole 40 antiangiogenic agents 40 maximal 40 knee flexion 40 rituximab monotherapy 40 plasma glucose 40 corticosteroid dose 40 polysomnography PSG 40 dosing frequency 40 QTc interval prolongation 40 subcutaneous infusion 40 correlation coefficients 40 resolves spontaneously 40 thromboses 40 inverse ProFunds returns 40 variability 40 prolonged immobilization 40 pharmacodynamic parameters 40 lifespan 40 nonobstructive CAD 40 ancrod 40 baseline LDH 40 frequent awakenings 40 wavelength lasers 40 ipsilateral stroke 40 interrupt latency 40 intraventricular 40 shelflife 40 ovulatory 40 LTV ratios 40 care hospitals LTACHs 40 kurtosis 40 serum potassium levels 40 disease progression TTP 40 term nonprogressors 40 painful erections 40 pulmonary dysfunction 40 adjuvant tamoxifen 40 plasma glucose levels 40 LFTs 40 specified 40 apneic 40 divalproex 40 cm sec 40 leukocyte telomere length 40 anovulatory 40 OFZ curve 40 nadolol 40 postdischarge 40 serum ALT 40 Sleep disordered breathing 40 mg Pycnogenol 40 psychodynamic psychotherapy 39 LS BMD 39 cortisol secretion 39 shorter maturities 39 antidepressant pharmacotherapy 39 esophageal pH 39 #mg q8h 39 value ratios LTVs 39 postoperatively 39 Persistent Sleep 39 mg/m2/day 39 p = NS 39 adenoma recurrence 39 AMOR IPAT 39 plasma cortisol 39 liver biopsies 39 vigorous aerobic 39 repolarization 39 serum homocysteine 39 ICD shocks 39 span 39 insulin detemir 39 PANHANDLE Soil moisture 39 atrial tachyarrhythmias 39 kilobases 39 vigorous exertion 39 Secondary endpoints include 39 pretreatment baseline 39 electrical cardioversion 39 implied volatilities 39 Index CDAI 39 obstructive apnea 39 predefined 39 QT interval 39 HAART regimen 39 SHBG levels 39 short 39 1Hz 39 preoperative radiotherapy 39 spontaneous bowel movements 39 diurnal 39 creatine supplementation 39 chronic insomniacs 39 oral prednisone 39 psychomotor speed 39 LIBOR indexed 39 Marquis Colston 39 dose corticosteroids 39 postprandial glucose 39 TURBT 39 axial length 39 metabolic parameters 39 kyr 39 carotid IMT 39 Fig. 2D 39 amenorrhea 39 FOLPI 39 5 HTTLPR 39 cosmic ray flux 39 CK MB 39 aortic crossclamp 39 cerebral ischemic 39 bullspread 39 Immediate annuities 39 baseline CD4 39 ZOMIG Nasal Spray 39 using slickwater 39 cessations 39 Takafumi Yamawaki senior 39 p = #.# [003] 39 acetazolamide 39 dose proportional pharmacokinetics 39 amplitudes 39 carbohydrate oxidation 39 weekly subcutaneous injections 39 Milstar II 39 neurologic sequelae 39 FOSRENOL ® 39 Exercisers 39 latencies 39 secondary efficacy endpoint 39 inhaled budesonide 39 quetiapine 39 GnRH agonist 39 intravitreal injections 39 Crohn Disease Activity 39 Guard Byron Isom 39 QRS interval 39 hypoglycemia unawareness 39 MIRAPEX 39 femoral shaft fracture 39 wavelength tunability 39 ml min 39 CD# upregulation 39 rate mortgages FRMs 39 oral prednisolone 39 supercontinuum generation 39 serum calcium levels 39 milliamp 39 recurrent ischemic 39 5kHz 39 unrefreshing sleep 39 NIHSS score 39 PSQI 39 cancellable 39 QT syndrome 39 Cluster headaches 39 dose prednisone 39 abdominal circumference 39 VaR calculations 39 hemorrhagic complications 39 antiretroviral naive 39 systolic ejection 39 AUC0 39 Vojo Vukovic MD Ph.D. 39 μmol L 39 hippocampal volumes 39 timings 39 negative convexity 39 artificially lengthen 39 Free Survival PFS 39 excitation wavelengths 39 1ns 39 peri procedural 39 serum aminotransferase levels 39 bimodal distribution 39 untreated psychosis 39 Shortening 39 postvaccination 39 comorbid conditions 39 serum magnesium 39 comorbid disorders 39 submaximal exercise 39 virologic responses 39 akinesia 39 airflow obstruction 39 mg kg dose 39 inotropes 39 peak VO2 39 estimated glomerular filtration 39 tertiles 39 #ms [001] 39 pamidronate 39 physiologic parameters 39 glycemia 39 ng dL 39 product lifecycles 39 atazanavir ritonavir 39 desaturation 39 ambulation 39 mortality morbidity 39 SOUTH Soil moisture 39 laddered portfolio 39 Value LTV 39 inhaled anticholinergics 39 Lifespans 39 vigorous aerobic exercise 39 Febrile neutropenia 39 AUC0 #hr 39 radiographic progression 39 DAPT 38 nevirapine regimen 38 moderately emetogenic 38 HbA1C levels 38 Furnished apartments 38 postoperative hemorrhage 38 DUTs 38 Banker Acceptances 38 pCR 38 virologic breakthrough 38 HBeAg seroconversion 38 dalteparin 38 Symptom severity 38 related hematological toxicity 38 μg liter 38 LUTS 38 odds ratios ORs 38 acting insulin analogues 38 saccades 38 hypofractionated radiation 38 GI motility 38 hypoglycemic episodes 38 deterministic latency 38 maturity WAM 38 CCyR 38 predefined threshold 38 maximal aerobic 38 laddered 38 APTIVUS r 38 maximal aerobic capacity 38 peak plasma concentrations 38 Oswestry Disability Index 38 LATUDA 38 Skin sterol 38 Calorie restriction 38 pulmonary exacerbations 38 redefaults 38 gene APOE 38 serum bicarbonate 38 apneas 38 daytime naps 38 asystole 38 thromboprophylaxis 38 postacute care 38 symptomatic VTE 38 partial thromboplastin 38 intravenous tPA 38 intermediately 38 afterload 38 dated gilts 38 Left Ventricular Ejection Fraction 38 Bonferroni correction 38 dosage regimen 38 #kbit s [002] 38 2x 3x 38 postoperative complications 38 2dB 38 categorical variables 38 mg QD 38 intravenous dosing 38 allostatic 38 runtimes 38 RLS symptoms 38 optimal dosing 38 virologic response 38 fluid viscosity 38 Kaplan Meier survival 38 serum urate 38 x ULN 38 inhomogeneous 38 ankle dorsiflexion 38 alteplase 38 demonstrated clinically meaningful 38 microampere 38 cortical regions 38 HbA 1c levels 38 braking distances 38 Geomagnetic storms 38 min #mn 38 isotherm 38 colorectal adenoma 38 urinary sodium excretion 38 triacylglycerol concentrations 38 percutaneous intervention 38 divalproex sodium 38 low dose cytarabine 38 seminomas 38 release fampridine tablets 38 hypoglycemic events 38 shortens 38 Triple witching 38 #mV [001] 38 Cmax 38 titration phase 38 magnon 38 macrovascular events 38 varying maturities 38 flutamide 38 living ADLs 38 Fig. 2A 38 urinary albumin excretion 38 mIU ml 38 antiepileptic medications 38 ziprasidone 38 length 38 Ecotones Duet 38 mso font pitch 38 baroreceptor 38 overt nephropathy 38 oral anticoagulation 38 sUA levels 38 milliseconds 38 predefined criteria 38 PASI scores 38 ml kg 38 fructosamine 38 echocardiographic parameters 38 histologies 38 symptom severity 38 upmoves 38 ventricular tachyarrhythmias 38 input impedance 38 interannual 38 maximal oxygen 38 chronicity 38 mL kg 38 channel bandwidths 38 bezafibrate 38 incidence ≥ 38 PRADAXA #mg 38 #mg doses [002] 38 residual platelet reactivity 38 HbA1c levels 38 System IPSS 38 IQR 38 polytherapy 38 L dopa 38 PFPS 38 posttransplant 38 poststroke 38 PM#.# exposure 38 #mg QD [001] 38 rapid virologic response 38 FAR WEST Soil moisture 38 resonance frequency 38 acute asthma exacerbations 38 gain amplifiers VGAs 38 randomisation 38 Paliperidone 38 creatine kinase MB 38 Hemopurifier ® treatments 38 Galil CPI 38 adaptively 38 systolic dysfunction 38 ug kg 38 SCr 38 combinability 38 V# max 38 intravenous cyclophosphamide 38 hypopneas 38 8kHz 38 λ 38 distinct substructures 38 alanine aminotransferase ALT 38 acting beta agonists 38 dyskinesias 38 Preterm infants 38 kilopascals 38 UV irradiation 38 inhaled tobramycin 38 pulsed lasers 38 systemic corticosteroids 38 FFNS 38 HER2 expression 38 ADAS Cog 38 Martin Gibala 38 covariance 38 anti miRs targeting 38 QALE 38 UPDRS scores 38 Lucentis ranibizumab Genentech 38 #ns [002] 38 Somnolence 38 nanomolar 38 #-#,# [001] 38 neurocognitive outcomes 38 airflow limitation 38 bareboat employment 38 laser pulses 38 caloric burn 38 incontinence episodes 38 Distances vary 38 YMRS 38 smoothed sunspot number 38 ALT elevation 38 dephasing 38 p = .# [002] 38 COPD exacerbation 38 CorVue ™ 38 calorie restriction CR 38 1uA 38 physiologic responses 38 TDF FTC 38 tipranavir r 38 acting inhaled anticholinergic 38 mg orally 38 bronchodilators 38 reproducible measurements 38 wore pedometers 37 offpeak 37 severe exacerbations 37 RLAI 37 peri menopause 37 platelet reactivity 37 AGILECT R 37 physiological adaptations 37 nanosecond pulses 37 F FDG PET 37 Brugada syndrome 37 euribor 37 glucose tolerance 37 postoperative AF 37 bronchodilation 37 hemoglobin concentrations 37 solifenacin 37 CAG repeats 37 adenotonsillectomy 37 rituximab Rituxan ® 37 ADAS cog 37 hyperalgesia 37 basal metabolic 37 Visual acuity 37 reactive intermediates 37 #.#uA 37 dose cyclophosphamide 37 sleep apnea narcolepsy 37 events TEAEs 37 erosive esophagitis 37 reliabilities 37 NB UVB 37 methotrexate monotherapy 37 luteal phase 37 mileages 37 gastric acidity 37 #.#ns 37 respirable droplets delivered 37 Pattern Trapper ADVANCED Short 37 oligohydramnios 37 rearfoot 37 ventricular tachyarrhythmia 37 temporal 37 L DOPA 37 affective psychosis 37 urethral strictures 37 bolus doses 37 Hazard Ratio = 37 serum sodium levels 37 parameter settings 37 wavelengths 37 inhaled glucocorticoids 37 anti miRs 37 preset 37 Score IPSS 37 fibrinolysis 37 uW 37 paclitaxel eluting stents 37 PSADT 37 K ras mutations 37 tachycardias 37 headache somnolence 37 Lumbar spine 37 loop diuretics 37 6MWD 37 photoperiodic 37 bronchoconstriction 37 dichotomous variables 37 gait disturbances 37 nonobese 37 Elapsed 37 glycosylated hemoglobin levels 37 premixed insulin 37 per deciliter mg 37 IBDQ 37 CR nPR 37 paroxysmal AF 37 glutamate glutamine 37 hemoglobin A1c levels 37 corticosteroid therapy 37 diurnal variation 37 androgen suppression therapy 37 geological timescales 37 external resistors 37 CMV reactivation 37 NNT = 37 prolonged QT intervals 37 Observational studies 37 Settlement Date shall 37 6MW distance 37 continuously abstinent 37 setpoints 37 randomized #:#:# 37 repair MTTR 37 hypobaric hypoxia 37 Dr. Cerhan 37 user settable 37 oral analgesics 37 incubations 37 EDSS score 37 electroencephalographic EEG 37 Secondary endpoints 37 endoscopic remission 37 dose regimen 37 frequencies 37 regression equations 37 TT genotype 37 CHD CVD 37 estrous cycles 37 hybrid ARMs 37 PCR OI 37 lengthening 37 1mA 37 maximally tolerated 37 AGHD 37 DAS# scores 37 neurologic progression 37 climate forcers 37 placebo controlled trials 37 amyloidogenic 37 cART 37 cerebrovascular accidents 37 Poisson regression 37 User selectable 37 Chronic pancreatitis 37 transgene expression 37 intramuscularly 37 rectal bleeding subscore 37 antiangiogenic therapy 37 endometrial carcinoma 37 clock opioid 37 nulliparous women 37 concurrent 37 percutaneous interventions 37 erections lasting 37 postoperative bleeding 37 nausea vomiting cramps 37 mg simvastatin 37 pulse amplitude 37 transaminases 37 comorbid psychiatric 37 Epley maneuver 37 arteriolar 37 URTI 37 autocorrelation 37 white matter hyperintensities 37 hyperintense lesions 37 correlations 37 recurrent venous thromboembolism 37 INRs 37 salmeterol fluticasone 37 Scale EDSS score 37 extendible 37 MMSE scores 37 multivariable adjustment 37 theta oscillations 37 cough wheezing 37 spectral bands 37 ug dose 37 standard deviation 37 hepatic enzymes 37 OGTT 37 PSA nadir 37 perceived exertion 37 body habitus 37 yield curve flattens 37 concomitant AEDs 37 solar minima 37 X ray pulses 37 SOUTHWEST Soil moisture 37 Quadruple witching 37 serum HCV RNA 37 rebleeding 37 ALTs 37 NIH CPSI 37 serum PTH 37 decadal scale 37 logistic regression models 37 intravenous IV infusion 37 IGFBP 37 femtosecond pulses 37 NATRECOR ® 37 headache dizziness fatigue 37 full mosiac pattern 37 enuresis 37 #.#kHz [001] 37 intravenous REOLYSIN 37 ribonucleic acid molecules 37 torsade de pointes 37 #mg/m# [001] 37 glycated hemoglobin levels 37 severe keratitis 37 Active Ulcerative Colitis 37 oral corticosteroid 37 mg q8h 37 Erectile Function IIEF 37 apnea hypopnea index 37 conventional IMRT 37 Mibor 37 dietary carbohydrate 37 angiographic restenosis 37 sub maximal 37 UBS E Tracs 37 CREL DI 37 CI -#.# 37 myocardial contractility 37 Soil moisture levels 37 Alerian MLP Infrastructure 37 racemic albuterol 37 serum lipid 37 telomere length 37 laser pulse 37 Charlson comorbidity index 37 fatal arrhythmic 37 intravenous vancomycin 37 neurodevelopmental outcome 37 interconversion 37 Aerobic exercise 37 leukotriene modifiers 37 evaluable subjects 37 electromyographic 37 interobserver 37 6MWT 37 loss severities 37 correlated 37 anagen phase 37 VQT 37 cytoreduction 37 Triglyceride levels 37 alicaforsen enema 37 lactate dehydrogenase 37 mild renal impairment 37 prespecified 37 nonmetastatic prostate cancer 37 MIRP 37 synchronous 37 Index CDAI score 37 virological failure 37 squatting kneeling 37 FACIT 37 2x 4x 37 Evaluable 37 concomitant medications 37 Dr. Chenchen Wang 37 inpatient hospitalizations 37 uM 37 serum lipid levels 37 oral olanzapine 37 DAF #a 37 β blockers 37 fluticasone salmeterol 37 dayrate amounts 37 aromatase inhibitor therapy 37 foveal thickness 37 coronary stenosis 37 dysmenorrhoea 37 cosmic ray intensity 37 Scale EDSS 37 atheromatous 37 pretransplant 37 histograms 37 fasting glucose levels 37 typically 37 interindividual variability 37 tezampanel NGX# 37 intersessions 37 dose Iluvien 37 coverage ratios DSCR 37 selegiline 37 symptom exacerbation 37 nonvertebral fractures 37 death reinfarction 37 5Hz 37 Hormonal therapy 37 2x leveraged 37 lactate dehydrogenase LDH 37 Kaplan Meier curves 37 maximal doses 37 Venous thromboembolism 37 A1c levels 37 bpm beats 37 prothrombin 37 curve inversion 37 hertz Hz 37 ω 37 μg doses 37 varying intensities 37 anagen 37 iShares Lehman 37 ROIs 37 nonpeak hours 37 laps/#m#.#s 37 NOB spreads 37 thrombocytopenic patients 37 irregular menstrual periods 37 postdose 37 serum phosphate 37 retinal thickness 37 sleep disturbances 37 theta 36 picometers 36 plasma glucose concentrations 36 symptom flare ups 36 nonfasting 36 + 2EV 36 RLS sufferers 36 Frequency 36 placebo dummy pill 36 nonoperative treatment 36 #mg/day [002] 36 asthma exacerbation 36 adjunctive placebo 36 repo counterparties 36 theta waves